Updated Jul 16, 2026
CURTIS NICHOLAS T has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Nicholas T Curtis is the Chief Executive Officer of Lensar, Inc. (LNSR), a medical device company focused on femtosecond laser systems for cataract surgery, as reflected in the 2026-01-13 SEC filing. Under his leadership, Lensar aims to advance imaging, planning, and precision in cataract procedures with its LENSAR Laser System portfolio.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | LNSR | LENSAR, Inc. | A — Grant or award | 130.7K | $0.00 | |
| 2026-05-08 | LNSR | LENSAR, Inc. | J — Other acquisition / disposition | 0 | $0.00 | |
| 2026-02-20 | LNSR | LENSAR, Inc. | J — Other acquisition / disposition | 0 | $0.00 | |
| 2026-01-13 | LNSR | LENSAR, Inc. | J — Other acquisition / disposition | 0 | $0.00 |
Nicholas T Curtis is the Chief Executive Officer of Lensar, Inc. (LNSR), a medical device company focused on femtosecond laser systems for cataract surgery, as reflected in the 2026-01-13 SEC filing. Under his leadership, Lensar aims to advance imaging, planning, and precision in cataract procedures with its LENSAR Laser System portfolio.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CURTIS NICHOLAS T profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.